Replies to LegCo questions
LCQ22: Colorectal Cancer Screening Pilot Programme
Following is a question by the Hon Paul Tse and a written reply by the Secretary
for Food and Health, Dr Ko Wing-man, in the Legislative Council today (January
21):
Question:
At the end of this year the earliest, the Government will launch the Colorectal
Cancer (CRC) Screening Pilot Programme (the Programme), which will cost $420
million, to subsidise people of specific age groups for CRC screening. It has
been reported that the authorities intend to outsource colonoscopy services to
private healthcare institutions and will conduct a survey on the relevant market
fees in the first quarter of this year to determine the amount of subsidy.
However, the media have found that, prior to the market survey conducted by the
Government, three private hospitals have already raised their fees for
colonoscopy services, with one of them raising its fees by almost 30%. Some
patient groups are worried that such increases would have impact on the result
of the market survey, push up public expenditure and unreasonably increase the
gains of private hospitals. In this connection, will the Government inform this
Council:
(1) whether it has approached the private hospitals to gain an understanding
about the reasons to substantially raise the fees for colonoscopy services
before taking up the outsourcing services;
(2) whether it has assessed the impacts of the fees for colonoscopy services
having been raised substantially by private hospitals on the estimated
expenditure, number of beneficiaries and the overall effectiveness of the
Programme; and
(3) whether the authorities will introduce competition by allowing eligible
private clinics or medical centres to take part in the Programme when they
outsource the colonoscopy services; of the other measures to be put in place by
the authorities so that the Programme may benefit more members of the public?
Reply:
President,
In 2012, colorectal cancer became the second most common cancer, after lung
cancer, in Hong Kong. There were 4 563 newly diagnosed colorectal cancer cases
in that year, accounting for 16.4% of all new cancer cases. In 2013, colorectal
cancer was the second most common cause of cancer death, resulting in a total of
1 981 registered deaths and accounting for 14.6% of all cancer deaths. As the
risk of colorectal cancer increases significantly from age 50, persons aged 50
to 75 should discuss with their doctor and consider screening for colorectal
cancer.
In view of a growing and ageing population, the number of new colorectal cancer
cases and related healthcare burden are expected to continue to increase in
future. In the light of the above, the Government announced in the 2014 Policy
Address and the 2014/15 Budget that it would allocate funding of around $420
million in the five years starting from 2014/15 for the study and implementation
of a pilot programme to subsidise colorectal cancer screening for specific age
groups.
Regarding the three parts of the question, my consolidated reply is as follows:
The Department of Health (DH), with support from the Hospital Authority (HA),
established in January 2014 a multi-disciplinary taskforce (taskforce) with a
number of representatives from the medical sector to embark upon the study and
planning of the Colorectal Cancer Screening Pilot Programme (Pilot Programme).
The taskforce comprises representatives from the HA, relevant Academy Colleges,
medical associations, primary care doctors, academia and non-governmental
organisation. The taskforce is responsible for tasks pertaining to the planning,
implementation, publicity and evaluation of the Pilot Programme, including
determination of inclusion criteria for participation in the Pilot Programme,
method of screening, funding model, and operational logistics, etc.
The taskforce has identified faecal immunochemical test (FIT) as the screening
method for use in the Pilot Programme. Primary care doctors will issue FIT tubes
to participants. Where participants whose stool samples are found to contain
minute amounts of blood, they will be referred by their primary care doctors for
colonoscopy by specialists enrolled on a public-private partnership basis.
Colonoscopists who are interested in participating in the Pilot Programme must
meet requirements set out in terms of qualification, premises and facilities, as
well as service quality and standard. The colonoscopy would not be confined to
hospitals or medical centres. In the planning process, the DH has maintained
close communication with various stakeholders in the medical field to enlist
their active support and participation in the Pilot Programme.
To encourage eligible citizens to actively participate in the Pilot Programme
and complete the screening process, apart from subsidising FIT, the
Administration will provide subsidy to participants found to have positive FIT
results for undertaking colonoscopy. The amount and details of subsidy will be
determined by taking into consideration market practice, experience of existing
subsidy schemes as well as issues that relate to fairness and equity,
affordability and accessibility. To obtain a better understanding of the market
situation and price information of colonoscopy services, the DH and the HA
commissioned a market survey between July and August 2014. Moreover, the Hong
Kong Medical Association conducted the Doctors' Fee Survey around the same time
and these findings will serve as useful reference for the Administration when
considering the details of the subsidy. The findings of the above studies reveal
that there is adequate supply of service providers to cope with the demand
generated from the Pilot Programme.
The Pilot Programme aims at gathering local experience of the colorectal cancer
screening services and collecting relevant data to generate evidence and
recommendations, thus facilitating the Administration to consider whether and
how best colorectal cancer screening may be provided to the wider population in
the future. We are working on a publicity strategy to promote the Pilot
Programme with the aim of increasing participation among eligible individuals
and healthcare professionals.
Ends/Wednesday, January 21, 2015
Issued at HKT 12:31
NNNN